ClearTrial to Present Analysis of Clinical Study Costing Methods at Leading Industry ConferencePresentation based on findings of independent clinical operations expert CHICAGO, IL – May 23, 2011 ClearTrial, the leading provider of software for the planning, forecasting, and tracking of clinical project and financial performance, today announced that Melinda Davis, Director, Clinical Services at ClearTrial, will present "A Comparative Analysis of Leading Clinical Study Costing Methods" at the CBI Clinical Trial Budgeting and Project Management conference in Princeton, New Jersey. The conference attracts clinical operations, clinical finance, outsourcing, and project management professionals seeking best practices for accurately and effectively forecasting, budgeting, and managing clinical trials.
Exploring the advantages and disadvantages of these methods, the presentation will also answer questions such as: Which costing method is the most accurate? What are the preferred methods in other industries that are facing cost constraints? Are there methods that can generate internal as well as outsourced costs? About ClearTrial® ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, an integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information visit http://www.cleartrial.com. ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners. For more information contact: Mike Lange |
